Japan Approves Daiichi And J&J's Alzheimer's Disease Drugs; Challenge Eisai'sAricept
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare has approved Daiichi Sanko's Memary (memantine) tablets and Janssen Pharma Reminyl (galantamine) oral disintegration tablets and oral liquid formulation to treat Alzheimer's disease